RxDoctor Payments Data

Henrique Hilario

Foot & Ankle Surgery · Shreveport, LANPI 1447696794

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Stryker at 40.9% of the total. Reporting peaked in 2019 at $5,251 and has fallen 79.8% since, to $1,063 in 2025. Among foot & ankle surgery clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,700in general payments, 2019–2025

Across 135 payments — averaging $101.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Midsouth Orthopedics Inc.$3K
  • Arthrex$3K
  • AbbVie$502
  • Paratek Pharmaceuticals, Inc.$490
  • Medtronic$274
  • plus $970 from 15 others

What the payments were for

  • Travel & lodging$2,86021%
  • Food & beverage$6,38847%
  • Education$4,09130%
  • Gifts$3613%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,700 in reported general payments places this provider in the 90th percentile of 92 foot & ankle surgery providers in Louisiana.

See all foot & ankle surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$378,998
Medicare patients
484
Services billed
33,903

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen128$1,178
Doxycycline Hyclate46$497
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen63$497
Gabapentin62$360
Cephalexin37$273
Acetaminophen-CodeineAcetaminophen With Codeine34$266
Clindamycin Hcl22$229
Ketorolac Tromethamine20$214
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$145
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$71
Meloxicam36$55
Methylprednisolone13$53
Cyclobenzaprine Hcl13$53
Tramadol Hcl21$52

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →